Skip to main content
Premium Trial:

Request an Annual Quote

Amprion SynTap Biomarker Test

Amprion has launched the SynTap Biomarker Test, a laboratory-developed test for the detection of a-synuclein aggregates, which is associated with a range of brain diseases. The test is for use in helping to diagnose synucleinopathies including Parkinson's disease, Lewy Body dementia, and multiple system atrophy. It can also help distinguish underlying synucleinopathies in other neurodegenerative diseases such as Alzheimer's disease. The test is based on Amprion's Seed Aggregation Assay, and it identifies prion-like a-synuclein aggregates in a few drops of cerebrospinal fluid. It is intended to be used with other clinical and diagnostic results to manage patients.